Table 2.
Echocardiographic Parameters at Baseline and Follow‐Up
| Parameters | High HE4 (n=29) | Low HE4 (n=36) | ||||
|---|---|---|---|---|---|---|
| Baseline | Follow‐up | P value | Baseline | Follow‐up | P value | |
| LVEDD, mm | 59±7.6 | 58±9.3 | 0.095 | 58±7.3 | 51±6.6 | <0.0001 |
| LVESD, mm | 51±9.6 | 48±12.6 | 0.035 | 49±8.5 | 38±8.1 | <0.0001 |
| LVEF, % | 33±11.1 | 39±14.0 | 0.006 | 35±9.5 | 49±9.4 | <0.0001 |
| LVEDVi, mL/m2 | 97±34.1 | 90±34.6 | 0.118 | 90±28.7 | 59±14.6 | <0.0001 |
| LVESVi, mL/m2 | 68±30.7 | 59±32.4 | 0.034 | 59±22.8 | 31±10.2 | <0.0001 |
| LAD, mm | 42±7.8 | 43±7.9 | 0.426 | 40±7.4 | 38±7.0 | 0.011 |
Values are mean±SD. The parameters at baseline and follow‐up were compared using a paired t test. HE4 indicates human epididymis protein 4; LAD, left atrium diameter; LVEDD, left ventricular end‐diastolic diameter; LVEDVi, left ventricular end‐diastolic volume index; LVEF, left ventricular ejection fraction; LVESD, left ventricular end‐systolic diameter; and LVESVi, left ventricular end‐systolic volume index.